Alvesco and Injection site bruising - a phase IV clinical study of FDA data

Summary:

Injection site bruising is reported as a side effect among people who take Alvesco (ciclesonide), especially for people who are female, 40-49 old, also take Xolair, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Injection site bruising when taking Alvesco. It is created by eHealthMe based on reports of 13,009 people who have side effects when taking Alvesco from the FDA, and is updated regularly.

What is Alvesco?

Alvesco has active ingredients of ciclesonide. It is often used in asthma. eHealthMe is studying from 13,134 Alvesco users. Check the latest studies of Alvesco.

What is Injection site bruising?

Injection site bruising is found to be associated with 1,062 drugs and 1,051 conditions by eHealthMe. Check the latest studies of Injection site bruising.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

13,009 people reported to have side effects when taking Alvesco.
Among them, 114 people (0.88%) have Injection site bruising.

Could Alvesco cause Injection site bruising?

Among these 114 people:

What is the gender of people who have Injection site bruising when taking Alvesco? *

Click here to view

What is the age of people who have Injection site bruising when taking Alvesco? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Alvesco and have Injection site bruising?

- Check whether Injection site bruising is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alvesco:

Alvesco (13,134 reports)

Injection site bruising treatments and more:

Injection site bruising (75,796 reports)

How severe was Injection site bruising and when was it recovered:

Injection site bruising in Alvesco

Expand to all the drugs that have ingredients of ciclesonide:

Injection site bruising and drugs with ingredients of ciclesonide

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alvesco:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site bruising:

Injection site bruising (1,062 drugs)

Browse all the conditions that are associated with Injection site bruising:

Injection site bruising (1,051 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ciclesonide (the active ingredients of Alvesco) and Alvesco (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.